Gastrointestinal (GI): NSAIDs that block COX-one activity have correlations with GI problems as a result of inhibition on the synthesis of gastroprotective agents including PGE2 together with other prostaglandins. This inhibition causes lessened mucin output by gastric epithelial cells, a lot less bicarbonate secretion, and less epithelial mobile turnover, between https://edwardy691jpu1.hazeronwiki.com/user